An Open-Label, Extension Study to Assess the Safety and Seizure Frequency Associated with Long-Term Oral Lacosamide for Uncontrolled Primary Generalized Tonic-Clonic Seizures in Subjects wit Idiopathic Generalized Epilepsy (SP0962)

Grants and Contracts Details

StatusFinished
Effective start/end date4/1/103/31/12

Funding

  • Schwarz BioSciences Inc: $4,410.00